Cellular Intelligence

Cellular Intelligence

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Cellular Intelligence is developing a foundational AI model to predict and simulate how cells respond to external signals, addressing the core challenge of context-dependent cellular behavior. The company leverages a proprietary, high-throughput data generation platform and a world-class scientific team to train transformer models on massive-scale perturbation datasets. Its long-term goal is to create a universal simulation engine that can rationally design protocols for regenerative medicine, predict drug effects, and model diseases, thereby accelerating therapeutic discovery.

Regenerative MedicineOncologyAutoimmune Disorders

Technology Platform

Proprietary capsule-based data generation platform combined with transformer AI models to build a universal virtual cell-signaling model that predicts dynamic cellular responses to external perturbations.

Opportunities

The platform addresses multi-billion dollar bottlenecks in cell therapy manufacturing and drug discovery by enabling predictive, in-silico design of biological protocols.
The convergence of AI adoption in biopharma and advances in synthetic biology creates a powerful tailwind for a validated virtual cell model.

Risk Factors

The core technical ambition of building a universal model of cell signaling is extremely high-risk and may not achieve sufficient accuracy for commercial application.
The company also faces intense competition from other well-funded AI biology firms and must navigate the uncertain path to commercialization for a foundational platform technology.

Competitive Landscape

Competes with other AI-driven biology companies like Recursion, Insitro, and Google's Isomorphic Labs, which are also building predictive models of biology. Cellular Intelligence differentiates by focusing specifically on the dynamic, combinatorial signaling logic that determines cell fate, using a proprietary high-throughput stem cell perturbation platform to generate its training data.